Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 18:11:613832.
doi: 10.3389/fneur.2020.613832. eCollection 2020.

Neurologic Care of COVID-19 in Children

Affiliations
Review

Neurologic Care of COVID-19 in Children

Susana Boronat. Front Neurol. .

Abstract

Most children with SARS-CoV-2 infection have relatively mild clinical symptoms without fever or pneumonia, although severe cases with multiple-organ failure have been reported. Neurological symptoms, which have been mainly reported in adults, are very rare in children. This article will review 2 different aspects of neurological involvement related to this infection in children. In the first part, we will review the neurological abnormalities reported in children caused by this viral infection. Adults frequently report muscle pain, headache, anosmia, dysgeusia, and occasionally more severe central or peripheral nervous system damage. Neurological involvement seems infrequent in children, although some cases have been reported. In the second part, we will discuss the COVID-19 pandemic impact on the healthcare system of some countries, causing collateral damage to general pediatric care and in particular to those children affected with chronic diseases, mainly neurological conditions, including autism, intellectual disability, attention deficit and hyperactivity disorder (ADHD), neuromuscular disorders, cerebral palsy, and epilepsy, and patients needing neurosurgical procedures.

Keywords: SARS-CoV-2; behavior; child abuse; epilepsy; neurocognitive; seizures; stress.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. . SARS-CoV-2 infection in children. N Engl J Med. (2020) 382:1663–5. 10.1056/NEJMc2005073 - DOI - PMC - PubMed
    1. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. (2020) 39:355–68. 10.1097/INF.0000000000002660 - DOI - PMC - PubMed
    1. Moreno-Galarraga L, Taveras EM. COVID-19 disease in children: not as mild as we have been led to believe. World J Pediatr. (2020) 16:426–7. 10.1007/s12519-020-00380-2 - DOI - PMC - PubMed
    1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683–90. 10.1001/jamaneurol.2020.1127 - DOI - PMC - PubMed
    1. Wang L, Shen Y, Li M, Chuang H, Ye Y, Zhao H, et al. . Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol. (2020) 267:2777–89. 10.1007/s00415-020-09974-2 - DOI - PMC - PubMed

LinkOut - more resources